This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Feb;20(2):117-9.

doi: 10.1097/gme.0b013e31827c44bd.

Denosumab: an antifracture therapy for postmenopausal women with osteoporosis

Xuezhi Jiang, Peter F Schnatz

PMID: 23299707
DOI: 10.1097/gme.0b013e31827c44bd

Editorial

Denosumab: an antifracture therapy for postmenopausal women with osteoporosis

Xuezhi Jiang et al. Menopause. 2013 Feb.

. 2013 Feb;20(2):117-9.

doi: 10.1097/gme.0b013e31827c44bd.

Authors

Xuezhi Jiang, Peter F Schnatz

PMID: 23299707
DOI: 10.1097/gme.0b013e31827c44bd

No abstract available

PubMed Disclaimer

Comment on

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.
Simon JA, Recknor C, Moffett AH Jr, Adachi JD, Franek E, Lewiecki EM, McClung MR, Mautalen CA, Ragi-Eis S, Nicholson GC, Muschitz C, Nuti R, Törring O, Wang A, Libanati C. Simon JA, et al. Menopause. 2013 Feb;20(2):130-7. doi: 10.1097/gme.0b013e318267f909. Menopause. 2013. PMID: 23010883 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information